FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283020691> ?p ?o ?g. }

• W4283020691 abstract "The fact that viruses cause human cancer dates back to the early 1980s. By reprogramming cellular signaling pathways, viruses encoded protein that can regulate altered control of cell cycle events. Viruses can interact with a superfamily of membrane bound protein, receptor tyrosine kinase to modulate their activity in order to increase virus entrance into cells and promotion of viral replication within the host. Therefore, our study aimed at screening of inhibitors of tyrosine kinase using natural compounds from olive. Protein tyrosine kinase (PTK) is an important factor for cancer progression and can be linked to coronavirus. It is evident that over expression of Protein tyrosine kinase (PTK) enhance viral endocytosis and proliferation and the use of tyrosine kinase inhibitors reduced the period of infection period. Functional network studies were carried out using two major PTKs viz. Anaplastic lymphoma kinase (ALK) and B-lymphocytic kinase (BTK). They are associated with coronavirus in regulation of cell signaling proteins for cellular processes. We virtually screened for 161 library of natural compounds from olive found overexpressed in ALK and BTK in metastatic as well as virus host cells. We have employed both ligand and target-based approach for drug designing by high throughput screening using Multilinear regression model based QSAR and docking. The QSAR based virtual screening of 161 olive nutraceutical compounds has successfully identified certain new hit; Wedelosin, in which, the descriptor rsa (ratio of molecular surface area to the solvent accessible surface area) plays crucial role in deciding Wedelosin’s inhibitory potency. The best-docked olive nutraceuticals further investigated for the stability and effectivity of the BTK and ALK during in 150 ns molecular dynamics and simulation. Post simulation analysis and binding energy estimation in MMGBSA further revealed the intensive potential of the olive nutraceuticals in PTK inhibition. This study is therefore expected to widen the use of nutraceuticals from olive in cancer as well as SARS-CoV2 alternative therapy." @default.
• W4283020691 created "2022-06-18" @default.
• W4283020691 creator A5005369110 @default.
• W4283020691 creator A5007282805 @default.
• W4283020691 creator A5010731574 @default.
• W4283020691 creator A5014844986 @default.
• W4283020691 creator A5049853063 @default.
• W4283020691 creator A5052557572 @default.
• W4283020691 creator A5060283241 @default.
• W4283020691 creator A5064062758 @default.
• W4283020691 creator A5077779755 @default.
• W4283020691 creator A5077894654 @default.
• W4283020691 creator A5082559837 @default.
• W4283020691 creator A5083105018 @default.
• W4283020691 creator A5084175363 @default.
• W4283020691 date "2022-03-08" @default.
• W4283020691 modified "2023-09-30" @default.
• W4283020691 title "Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals" @default.
• W4283020691 cites W1531539580 @default.
• W4283020691 cites W17944005 @default.
• W4283020691 cites W1970799005 @default.
• W4283020691 cites W1972650408 @default.
• W4283020691 cites W1972758026 @default.
• W4283020691 cites W1976499671 @default.
• W4283020691 cites W1981045787 @default.
• W4283020691 cites W1982177423 @default.
• W4283020691 cites W1988337892 @default.
• W4283020691 cites W1996851544 @default.
• W4283020691 cites W2014332852 @default.
• W4283020691 cites W2021832765 @default.
• W4283020691 cites W2025116694 @default.
• W4283020691 cites W2028415754 @default.
• W4283020691 cites W2033757486 @default.
• W4283020691 cites W2040258130 @default.
• W4283020691 cites W2086019403 @default.
• W4283020691 cites W2086634221 @default.
• W4283020691 cites W2096658459 @default.
• W4283020691 cites W2102634879 @default.
• W4283020691 cites W2105668062 @default.
• W4283020691 cites W2117400742 @default.
• W4283020691 cites W2130479394 @default.
• W4283020691 cites W2132629607 @default.
• W4283020691 cites W2134967712 @default.
• W4283020691 cites W2150851104 @default.
• W4283020691 cites W2154290668 @default.
• W4283020691 cites W2161279318 @default.
• W4283020691 cites W2169640413 @default.
• W4283020691 cites W2169678694 @default.
• W4283020691 cites W2204695023 @default.
• W4283020691 cites W2223809533 @default.
• W4283020691 cites W2292803562 @default.
• W4283020691 cites W2325789045 @default.
• W4283020691 cites W2336040088 @default.
• W4283020691 cites W2591910514 @default.
• W4283020691 cites W2604429430 @default.
• W4283020691 cites W2606150498 @default.
• W4283020691 cites W2747416722 @default.
• W4283020691 cites W2789940272 @default.
• W4283020691 cites W2790955314 @default.
• W4283020691 cites W2797353951 @default.
• W4283020691 cites W2888419953 @default.
• W4283020691 cites W2899070097 @default.
• W4283020691 cites W2910882956 @default.
• W4283020691 cites W3015573540 @default.
• W4283020691 cites W3018203086 @default.
• W4283020691 cites W3019103367 @default.
• W4283020691 cites W3021788307 @default.
• W4283020691 cites W3036997165 @default.
• W4283020691 cites W3046619251 @default.
• W4283020691 cites W3082864496 @default.
• W4283020691 cites W3091926957 @default.
• W4283020691 cites W3138363790 @default.
• W4283020691 cites W3149078497 @default.
• W4283020691 cites W3158217070 @default.
• W4283020691 cites W3170353867 @default.
• W4283020691 cites W3175124992 @default.
• W4283020691 cites W3192530076 @default.
• W4283020691 cites W4211075026 @default.
• W4283020691 doi "https://doi.org/10.3389/fphar.2021.812565" @default.
• W4283020691 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35356629" @default.
• W4283020691 hasPublicationYear "2022" @default.
• W4283020691 type Work @default.
• W4283020691 citedByCount "13" @default.
• W4283020691 countsByYear W42830206912022 @default.
• W4283020691 countsByYear W42830206912023 @default.
• W4283020691 crossrefType "journal-article" @default.
• W4283020691 hasAuthorship W4283020691A5005369110 @default.
• W4283020691 hasAuthorship W4283020691A5007282805 @default.
• W4283020691 hasAuthorship W4283020691A5010731574 @default.
• W4283020691 hasAuthorship W4283020691A5014844986 @default.
• W4283020691 hasAuthorship W4283020691A5049853063 @default.
• W4283020691 hasAuthorship W4283020691A5052557572 @default.
• W4283020691 hasAuthorship W4283020691A5060283241 @default.
• W4283020691 hasAuthorship W4283020691A5064062758 @default.
• W4283020691 hasAuthorship W4283020691A5077779755 @default.
• W4283020691 hasAuthorship W4283020691A5077894654 @default.
• W4283020691 hasAuthorship W4283020691A5082559837 @default.
• W4283020691 hasAuthorship W4283020691A5083105018 @default.
• W4283020691 hasAuthorship W4283020691A5084175363 @default.
• W4283020691 hasBestOaLocation W42830206911 @default.

• next